tranexamic acid
Generic: tranexamic acid
Labeler: baxter healthcare corporationDrug Facts
Product Profile
Brand Name
tranexamic acid
Generic Name
tranexamic acid
Labeler
baxter healthcare corporation
Dosage Form
INJECTION
Routes
Active Ingredients
tranexamic acid 100 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
43066-008
Product ID
43066-008_aa76c2c6-9374-44d5-a037-4e2b6ffea859
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212360
Listing Expiration
2026-12-31
Marketing Start
2020-07-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43066008
Hyphenated Format
43066-008
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tranexamic acid (source: ndc)
Generic Name
tranexamic acid (source: ndc)
Application Number
ANDA212360 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/mL
Packaging
- 10 CARTON in 1 BOX (43066-008-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (43066-008-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "aa76c2c6-9374-44d5-a037-4e2b6ffea859", "openfda": {"nui": ["N0000175634", "N0000175632"], "upc": ["0343066008017"], "unii": ["6T84R30KC1"], "rxcui": ["238720"], "spl_set_id": ["32750a05-6617-46e8-b9e7-04e613e6bf4b"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 CARTON in 1 BOX (43066-008-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (43066-008-01)", "package_ndc": "43066-008-10", "marketing_start_date": "20200701"}], "brand_name": "TRANEXAMIC ACID", "product_id": "43066-008_aa76c2c6-9374-44d5-a037-4e2b6ffea859", "dosage_form": "INJECTION", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "43066-008", "generic_name": "tranexamic acid", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRANEXAMIC ACID", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "100 mg/mL"}], "application_number": "ANDA212360", "marketing_category": "ANDA", "marketing_start_date": "20200701", "listing_expiration_date": "20261231"}